{"name":"Merry Life Biomedical Co., Ltd.","slug":"merry-life-biomedical-co-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"TML-6 Granules","genericName":"TML-6 Granules","slug":"tml-6-granules","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"TML-6 Granules","genericName":"TML-6 Granules","slug":"tml-6-granules","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMixwJBVV95cUxNWF9welVfdzA4bWFranM0SVVxOFNvLTEwRWViandGMVdhQklobTZfMkxXWjc4enBBSmRfRFlEWG51bzJOYVkwY1VxbkJRanRwN2Z5YUNtNUJxek9aZnNXeEF1N3JCNjZCX042RXJrWE5wNkN4QVhveGl1dTd4RHZBSEZ2eEJoeFYtYnNxc1pITUs1VjIyNXRQUkp1UlZYaXJCaHZTbDcxQzJUd3pvQmpPbXNXVkxBejhabV9YbWk0OXp2amc0STJnWmR2SnQzTnI1Z1lYOV92aC15RkI0UlBCeVBIR3NPWm5ENUUxZXNxWWlFcnRUN2VPOEt2ZVotd25JZUpzS2lZU1c3M1pzNFpSMkJRdnVvZVhSWTRaZG1kUGs5dG0wTW9SMEtnY0lDM3lSS3BieFdzY3BWUE9wMnlxd3dOQzFUZm8?oc=5","date":"2026-02-09","type":"trial","source":"prnewswire.com","summary":"MerryLife Biomedical Reports Positive Phase 1 Results and Plans for Global Phase 2 Trial for TML-6, an Oral Multi-Targeted Investigational Therapy for Alzheimer's Disease - prnewswire.com","headline":"MerryLife Biomedical Reports Positive Phase 1 Results and Plans for Global Phase 2 Trial for TML-6, an Oral Multi-Target","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxNSDRreFB1MTZWOTBBUllRc1ZETXRfYzhsZnEyUXVUSzJTcFE3bVF0VXFvQWt0QmZZV0tnSlNvN08tbW9GYVFuQU5GclE5azRwbTJUb1k2VFlJX3JsbXdlSU5iak5TcFNmREdqQl9wbjdZOUgzNkZYMlJlOUFrRlNYR0RNLXF6aUpYZjF6N3hjLXlMUQ?oc=5","date":"2025-07-17","type":"pipeline","source":"Yahoo Finance","summary":"Dementia Associated with Alzheimer’s Disease Drug Development Surges with 180+ Companies Pushing New Therapeutic Frontiers | DelveInsight - Yahoo Finance","headline":"Dementia Associated with Alzheimer’s Disease Drug Development Surges with 180+ Companies Pushing New Therapeutic Frontie","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwJBVV95cUxOSlhnTVdpQVl6R253ODhDNW1ZZ0d4MGgtX1hHM2NUbktfd1EwTXY3eUhnYVc2ekRJczg2azZNUFRlR2Z6Y1pkYUt4RUVwRmozVE5CSFo1T1hLU0ZycTZZTHlvV0RiMkllTktqSWlkcHZBa19xaXVqWGh5azIwMmltR2hpenVNSldIVkFuWVRkMGdIMUs1SUJ3SGk5QjVYY2o2RlVNNm1tLWFEUnlWcE1SeVFjdTJZdmk3S0RNV0g3cFFZTS1xZ2s2T2pDTFItdS1zazhVNTFlRmt2R0RCdXRlNVNianZHWTlSRHZuZ0FwMmlMQ0U5QkdIbVdqTVhnVDZOMXF5WVh0bm10NDhVcGlkRl9RMnFSUVU?oc=5","date":"2025-06-12","type":"trial","source":"prnewswire.com","summary":"Merry Life Launches Global Phase II Trial of TML-6, The First Drug Targeted at Autolysosome pathway for Therapy of Alzheimer's Disease - prnewswire.com","headline":"Merry Life Launches Global Phase II Trial of TML-6, The First Drug Targeted at Autolysosome pathway for Therapy of Alzhe","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifkFVX3lxTFB5V25EdEZxYzZTQ3dLTmwwbS1LN3RERHlqekRqOVFsM2JhS3lrT1N4QVZ6eFFrcUM2YkxQdFc3aXl4MXhrTUhTbHpHZlMtRVFTWFJFNGx6bmZDRkhRTHlZODNKSUxON3c4MG5GTC0wSHlLOUdQZ1AyN2hGZmFNZw?oc=5","date":"2025-02-24","type":"pipeline","source":"Wiley","summary":"Amyloid is associated with accelerated atrophy in cognitively unimpaired individuals - Wiley","headline":"Amyloid is associated with accelerated atrophy in cognitively unimpaired individuals","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwAFBVV95cUxPd1lEamZxRU15TlNiUHBkTjl0d3U1VllQLVU2TUF3LW43SFlzalAxLVplbnRvOTBtdHdVMnNCRXFweGx4UkxwVTI4M1IzekJnbDdmWnJ1TENpRHVWV0NBcGRtSmZlZ3NsbnNxSHZSeWJsZDM1ZHAydEUyTGNyNFNMTUpETVdwMVA1Vl84ZDdEQ3QxOTBiQ3dJWnMxS01HNURYeUtZNWNHeWFLc3dmdnAtU0VEWnhtTzlLd0xCV3BXbjY?oc=5","date":"2024-06-07","type":"regulatory","source":"BioPharma APAC","summary":"MLB Receives FDA Approval for TML-6 IND Application to Treat Alzheimer's Disease - BioPharma APAC","headline":"MLB Receives FDA Approval for TML-6 IND Application to Treat Alzheimer's Disease","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMihgFBVV95cUxQSUdFZzlhTHJEUk15WXNyNHRQdnR4Rjhuc3llMDhRUDBiTnJ3eU5NRTNqNVZCSWpacXdzVnlGbUpDMlVza2JPVmk5YUhNWVlJOHZUYjZRbjBSWU9iNnVlYTVFOWprNjdPcFFrUGg3Yk9nVUFLU3dQNFJuYlpCTGF1azFBS2JxZw?oc=5","date":"2022-11-14","type":"pipeline","source":"Fierce Pharma","summary":"2022's Fiercest Women in Life Sciences - Fierce Pharma","headline":"2022's Fiercest Women in Life Sciences","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_1":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}